Cigna Group (CI)
(Delayed Data from NYSE)
$352.39 USD
+3.61 (1.04%)
Updated Apr 19, 2024 04:00 PM ET
After-Market: $352.63 +0.24 (0.07%) 7:58 PM ET
3-Hold of 5 3
A Value C Growth B Momentum B VGM
Average Brokerage Rating
Current ABR | 1.45 |
ABR (Last week) | 1.45 |
# of Recs in ABR | 21 |
Average Target Price | $385.53 |
LT Growth Rate | 11.50% |
Industry | Medical - HMOs |
Industry Rank by ABR | 172 of 252 |
Current Quarter EPS Est: | 6.17 |
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 15 | 15 | 15 | 14 | 11 |
Buy | 2 | 2 | 2 | 2 | 1 |
Hold | 4 | 4 | 4 | 4 | 7 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.45 | 1.45 | 1.45 | 1.48 | 1.76 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
3/8/2024 | Mizuho SecuritiesUSA | Ann K Hynes | Strong Buy | Strong Buy |
3/8/2024 | Truist Securities | David S Macdonald | Strong Buy | Strong Buy |
3/4/2024 | Cantor Fitzgerald & Co | Sarah James | Strong Buy | Strong Buy |
2/1/2024 | Stephens | Scott Fidel | Strong Buy | Strong Buy |
11/3/2023 | SVB Securities | Whit Mayo | Hold | Hold |
8/18/2023 | Edward D. Jones & Company | John Boylan | Not Available | Hold |
8/7/2023 | Raymond James | John W Ransom | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.